14:45-16:15
Parallel 3a: Gene delivery platforms
Chair: Karim Benabdellah, GENYO, Granada
14:45 Els Verhoeyen, ENS Lyon, Université de Nice ⓘ
INV15 Novel lentiviral pseudotypes for T and NK cell gene therapy and ‘nanoblades’ for efficient gene editing in hematopoietic gene therapy target cells and organoids
15:15 Pedro Berraondo, Program of Immunology and Immunotherapy, Cima Universidad de Navarra
INV16 Messenger RNA in cancer immunotherapy
15:45 Pilar Martin Duque, Universidad de Zaragoza
OR01 Use and isolation of maternal milk exosomes: New vector for genetic hNIS therapy and diagnostic in oncology
16:00 Carlos Blanco-Benitez, LentiStem Biotech. GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government.PTS Granada
OR02 Lent-On-Plus: An all-in-one transactivator-free doxycycline inducible LVs ready for clinical applications